Search research articles
Contact Us
Filters
Showing results (201-210 of 319) with videos related to
Page
of 32
Sort By:
Journal of Clinical Psychopharmacology
|
April 25, 2006
Risk factors for extrapyramidal symptoms during treatment with selective serotonin reuptake inhibitors, including cytochrome P-450 enzyme, and serotonin and dopamine transporter and receptor polymorphisms
Karin Hedenmalm, Cüneyt Güzey, Marja-Liisa Dahl, et al.
European Journal of Clinical Pharmacology
|
January 18, 2007
Antipsychotic-induced extrapyramidal symptoms in patients with schizophrenia: associations with dopamine and serotonin receptor and transporter polymorphisms
Cüneyt Güzey, Maria Gabriella Scordo, Edoardo Spina, et al.
Psychopharmacology
|
October 25, 2008
Studies of pharmacokinetic and pharmacodynamic properties of isoallopregnanolone in healthy women
Helena Hedström, Marie Bixo, Sigrid Nyberg, et al.
Journal of Clinical Medicine Research
|
March 3, 2012
Effect of serotonin reuptake inhibitors on pulmonary hemodynamics in humans
Hilde Pleym, Guri Greiff, Tom Mjorndal, et al.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke
|
January 12, 2017
[Re: Family planning, pregnancy and breastfeeding in multiple sclerosis]
Solveig T Holmsen, Gro C Havnen, Elisabet Nordmo, et al.
Pharmacoepidemiology and Drug Safety
|
April 18, 2021
Prenatal exposure to non-steroidal anti-inflammatory drugs and risk of attention-deficit/hyperactivity disorder: A follow-up study in the Norwegian mother, father and child cohort
Sarah Hjorth, Angela Lupattelli, Marte Handal, et al.
Forensic Science International
|
July 9, 2024
Retrospective screening of new psychoactive substances (NPS) in post mortem samples from 2014 to 2021
Per Ole M Gundersen, Daniel Pasin, Lars Slørdal, et al.
Forensic Science International
|
April 18, 2020
Retrospective screening of synthetic cannabinoids, synthetic opioids and designer benzodiazepines in data files from forensic post mortem samples analysed by UHPLC-QTOF-MS from 2014 to 2018
Per Ole M Gundersen, Sebastian Broecker, Lars Slørdal, et al.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke
|
September 27, 2023
[New tool for interpreting pharmacogenetic analyses]
Silja Skogstad Tuv, Olav Spigset, Elena Jensen, et al.
World Neurosurgery
|
December 21, 2021
Letter to the Editor Regarding "Cytotoxicity and Effect of Topical Application of Tranexamic Acid on Human Fibroblast in Spine Surgery"
Kjersti Ausen, Tuva Eikebrokk, Brita Vassmyr, et al.
Page
of 32
Search research articles
Search
Showing results (201-210 of 319) with videos related to
Sort By:
Page
of 32
Journal of Clinical Psychopharmacology
|
April 25, 2006
Risk factors for extrapyramidal symptoms during treatment with selective serotonin reuptake inhibitors, including cytochrome P-450 enzyme, and serotonin and dopamine transporter and receptor polymorphisms
Karin Hedenmalm, Cüneyt Güzey, Marja-Liisa Dahl, et al.
European Journal of Clinical Pharmacology
|
January 18, 2007
Antipsychotic-induced extrapyramidal symptoms in patients with schizophrenia: associations with dopamine and serotonin receptor and transporter polymorphisms
Cüneyt Güzey, Maria Gabriella Scordo, Edoardo Spina, et al.
Psychopharmacology
|
October 25, 2008
Studies of pharmacokinetic and pharmacodynamic properties of isoallopregnanolone in healthy women
Helena Hedström, Marie Bixo, Sigrid Nyberg, et al.
Journal of Clinical Medicine Research
|
March 3, 2012
Effect of serotonin reuptake inhibitors on pulmonary hemodynamics in humans
Hilde Pleym, Guri Greiff, Tom Mjorndal, et al.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke
|
January 12, 2017
[Re: Family planning, pregnancy and breastfeeding in multiple sclerosis]
Solveig T Holmsen, Gro C Havnen, Elisabet Nordmo, et al.
Pharmacoepidemiology and Drug Safety
|
April 18, 2021
Prenatal exposure to non-steroidal anti-inflammatory drugs and risk of attention-deficit/hyperactivity disorder: A follow-up study in the Norwegian mother, father and child cohort
Sarah Hjorth, Angela Lupattelli, Marte Handal, et al.
Forensic Science International
|
July 9, 2024
Retrospective screening of new psychoactive substances (NPS) in post mortem samples from 2014 to 2021
Per Ole M Gundersen, Daniel Pasin, Lars Slørdal, et al.
Forensic Science International
|
April 18, 2020
Retrospective screening of synthetic cannabinoids, synthetic opioids and designer benzodiazepines in data files from forensic post mortem samples analysed by UHPLC-QTOF-MS from 2014 to 2018
Per Ole M Gundersen, Sebastian Broecker, Lars Slørdal, et al.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke
|
September 27, 2023
[New tool for interpreting pharmacogenetic analyses]
Silja Skogstad Tuv, Olav Spigset, Elena Jensen, et al.
World Neurosurgery
|
December 21, 2021
Letter to the Editor Regarding "Cytotoxicity and Effect of Topical Application of Tranexamic Acid on Human Fibroblast in Spine Surgery"
Kjersti Ausen, Tuva Eikebrokk, Brita Vassmyr, et al.
Page
of 32